Advancement of clinical therapeutic research on glioma: A narrative review

As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In...

Full description

Saved in:
Bibliographic Details
Published in:Glioma (Mumbai, India) India), 2020-07, Vol.3 (3), p.119-125
Main Authors: Li, Fengping, Ma, Chao, Xu, Chengshi, Pan, Zhiyong, Li, Zhiqiang
Format: Article
Language:English
Subjects:
glioma
immunotherapy
radiochemotherapy
surgery
tumor-treating fields
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overall survival of these patients is unsatisfactory. In the recent decade, a few novel therapies, such as tumor-treating fields and immunotherapy, have been introduced in clinic. Before they can be widely used, many key factors, including efficacy, safety, and benefit ratio, should be fully evaluated. Therefore, more clinical trials are required to corroborate the results and conclusions of basic research and improve the current treatment strategies. In this article, we searched relevant literature published in the past 5 years in PubMed and China National Knowledge Infrastructure and reviewed the advancements of clinical therapeutic research on glioma.
ISSN:2589-6113
2589-6121
DOI:10.4103/glioma.glioma_18_20